Shariah compliance overview
Not HalalDenali Therapeutics Inc. (DNLI) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Denali Therapeutics Inc.
Denali Therapeutics Inc. is a biopharmaceutical firm, founded in 2013 and based in South San Francisco, California, which focuses on identifying and advancing treatments for neurodegenerative conditions within the United States.
Denali Therapeutics Inc. (DNLI) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 0.00%Limit 30%Pass
- Interest-bearing securities and assets
- 26.35%Limit 30%Pass
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Denali Therapeutics Inc. (DNLI). Current Akinda screening label: Not Halal.
